These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1963876

  • 1. Tumor-induced osteomalacia: pre- and postoperative biochemical findings.
    Leicht E, Biro G, Langer HJ.
    Horm Metab Res; 1990 Dec; 22(12):640-3. PubMed ID: 1963876
    [Abstract] [Full Text] [Related]

  • 2. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
    Weiss M, Schechter P, Bab I, Mekhmandarov S, Bank H, Eisenstein Z.
    Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Bone densitometry in a patient with hypophosphatemic osteomalacia.
    Negri AL, Bogado CE, Zanchetta JR.
    J Bone Miner Metab; 2004 Nov; 22(5):514-7. PubMed ID: 15316875
    [Abstract] [Full Text] [Related]

  • 5. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL.
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [Abstract] [Full Text] [Related]

  • 6. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL, Fang VS, Sugimoto J, Fredland A.
    Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
    [Abstract] [Full Text] [Related]

  • 7. Tumor-induced osteomalacia: clinical and basic studies.
    Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL.
    J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
    [Abstract] [Full Text] [Related]

  • 8. [Adult-onset sex-linked familial hypophosphatemic osteomalacia].
    Radó J, Haris A, Szebenyi B.
    Orv Hetil; 1997 Jun 29; 138(26):1683-8. PubMed ID: 9289682
    [Abstract] [Full Text] [Related]

  • 9. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K, Varga F, Nader A, Roschger P, Sieghart S, Zwettler E, Roetzer KM, Lang S, Weinkamer R, Klaushofer K, Fratzl-Zelman N.
    Calcif Tissue Int; 2009 Apr 29; 84(4):313-23. PubMed ID: 19219382
    [Abstract] [Full Text] [Related]

  • 10. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism.
    Bell NH, Epstein S, Shary J, Greene V, Oexmann MJ, Shaw S.
    J Bone Miner Res; 1988 Oct 29; 3(5):489-95. PubMed ID: 2848397
    [Abstract] [Full Text] [Related]

  • 11. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
    Drezner MK, Feinglos MN.
    J Clin Invest; 1977 Nov 29; 60(5):1046-53. PubMed ID: 908749
    [Abstract] [Full Text] [Related]

  • 12. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
    Liou HH, Chiang SS, Huang TP, Shieh SD, Akmal M.
    Miner Electrolyte Metab; 1994 Nov 29; 20(3):97-102. PubMed ID: 7816008
    [Abstract] [Full Text] [Related]

  • 13. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH, Irias JJ, Golabi M.
    Pediatrics; 1977 Sep 29; 60(3):343-8. PubMed ID: 197477
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF, Nagode LA, Steinmeyer CL, Renkes G.
    Res Commun Chem Pathol Pharmacol; 1994 Jan 29; 83(1):3-14. PubMed ID: 8165367
    [Abstract] [Full Text] [Related]

  • 15. Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers.
    Schwietert HR, Groen EW, Sollie FA, Jonkman JH.
    Clin Pharmacol Ther; 1997 Mar 29; 61(3):360-76. PubMed ID: 9084461
    [Abstract] [Full Text] [Related]

  • 16. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG, Gitelis S, Charters JR.
    Calcif Tissue Int; 1986 Jun 29; 38(6):358-62. PubMed ID: 3089559
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive testing in the diagnosis of osteomalacia.
    Bingham CT, Fitzpatrick LA.
    Am J Med; 1993 Nov 29; 95(5):519-23. PubMed ID: 7646591
    [Abstract] [Full Text] [Related]

  • 18. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE, Drezner MK, Hamdan JA, Mange M, Ahmad MS, Mubarak S, Nyhan WL.
    J Pediatr; 1986 Dec 29; 109(6):994-1000. PubMed ID: 3023599
    [Abstract] [Full Text] [Related]

  • 19. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
    Sato K, Nohtomi K, Demura H, Takeuchi A, Kobayashi T, Kazama J, Ozawa H.
    Bone; 1997 Jul 29; 21(1):57-64. PubMed ID: 9213008
    [Abstract] [Full Text] [Related]

  • 20. Hypoparathyroidism: a possible cause of osteomalacia .
    Drezner MK, Neelon FA, Jowsey J, Lebovitz HE.
    J Clin Endocrinol Metab; 1977 Jul 29; 45(1):114-22. PubMed ID: 874058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.